April 8, 2022 – Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less structural deterioration in the valve after five years compared with similar patients who had the biologic valve inserted surgically.

April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density lipoprotein (LDL), or “bad” cholesterol, and other lipids, to date there are no approved treatments to lower lipoprotein(a), a lesser-known driver of heart disease risk.

April 7, 2022 – The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing improvements in quality care delivery for heart attacks in low- and middle-income countries with the use of data collection and localized education around guideline-directed medical therapy, according to data from the program’s second year.

April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement procedure experienced fewer symptomless blood clots inside the heart valve replacement than patients who were treated with two antiplatelet drugs, according to data presented at the American College of Cardiology’s 71st Annual S

April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who received a novel investigational device intended to repair the defective valve experienced significant improvements in blood flow through the heart and in quality of life at one year, according to research pr

April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a multifaceted strategy to try to keep their blood pressure from dropping to a potentially dangerous low level immediately before, during and for up to two days after surgery made no difference in the rates of major cardiovascular events in the 30 days following surgery. The research was presented at the American College of Cardiology’s 71st Annual Scientific Session.

April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI).

April 6, 2022 – Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were 25% lower in 2021 than in 2020, and no deaths occurred among patients who had been vaccinated against COVID-19, according to data presented at the American College of Cardiology’s 71st Annual Scientific Session.

April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (CHF) patients, announced results of a clinical study demonstrating the efficacy of its contact-free tec

April 6, 2022 – Narrowed arteries can restrict blood flow to the heart. One treatment is inserting a stent — a small mesh tube — inside the artery to widen it. However, existing stents have problems that affect their performance.

Two University of Alabama at Birmingham researchers have been awarded a $2.6 million, four-year National Institutes of Health grant to evaluate a safer and more durable stent design, using techniques licensed by their UAB spinoff company, Endomimetics LLC.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now